Product Information
GS SLEEP AID ULTRA 25 MG TAB is a generic product labeled by L. Perrigo Company, priced at $0.1158 per EA under NDC 00113403262. Its NADAC has been published 58 times since Aug 27, 2025.
FDA first approved this application on Sep 18, 1996.
Strength
25 mg/1
Manufacturer
L. Perrigo CompanyNDC
00113403262
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOXYLAMINE SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA040167FDA Approved
9/18/1996
On Market Since
2/27/2025
Pharmacological Classes
Price Statistics
The NADAC for GS SLEEP AID ULTRA 25 MG TAB has been published 58 times since Aug 27, 2025, and over the history we have for it it has declined 2.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1158 per EA |
|---|---|
| All-time high | $0.1245 (Feb 11, 2026) |
| All-time low | $0.1158 (Sep 23, 2026) |
| 52-week high | $0.1245 |
| 52-week low | $0.1158 |
| Median price | $0.1229 |
| Average price | $0.1222 |
| Largest weekly change | -4.7% (Sep 23, 2026) |
| Weeks tracked | 58 |
| Tracking since | Aug 27, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
L. Perrigo Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
doxylamine succinate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antihistamine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GS SLEEP AID ULTRA 25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for GS SLEEP AID ULTRA 25 MG TAB, manufactured by L. Perrigo Company, is $0.1158 per EA (NDC 00113403262), effective Sep 30, 2026.
How has the price of GS SLEEP AID ULTRA 25 MG TAB changed over time?
Over the history we have for it, the NADAC for GS SLEEP AID ULTRA 25 MG TAB has declined 2.1%. It has been tracked across 58 weekly CMS publications since Aug 27, 2025.
What are the highest and lowest recorded NADAC prices for GS SLEEP AID ULTRA 25 MG TAB?
Since Aug 27, 2025, the NADAC for GS SLEEP AID ULTRA 25 MG TAB has ranged from a low of $0.1158 (Sep 23, 2026) to a high of $0.1245 (Feb 11, 2026), with a median of $0.1229 per EA.
Are there cheaper alternatives to GS SLEEP AID ULTRA 25 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as GS SLEEP AID ULTRA 25 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures GS SLEEP AID ULTRA 25 MG TAB?
GS SLEEP AID ULTRA 25 MG TAB (NDC 00113403262) is labeled by L. Perrigo Company, and CMS classifies it as a generic product.